Improved cancer therapy based on tumor associated antigens derived from cyclin D1

Improved cancer therapy based on tumor associated antigens derived from cyclin D1

  • CN 102,971,003 A
  • Filed: 06/01/2011
  • Published: 03/13/2013
  • Est. Priority Date: 06/02/2010
  • Status: Active Application
First Claim
Patent Images

1. One kind by or substantially form, be used for the treatment of the peptide of patient'"'"'s cancer by the aminoacid sequence that is selected from SEQ identification sequence number 1 to SEQ identification sequence number 18, a kind of comprise at least a by or the peptide that is substantially formed by the aminoacid sequence that is selected from SEQ identification sequence number 1 to SEQ identification sequence number 18, the compositions that is used for the treatment of patient'"'"'s cancer.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×